Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid
Clinical trial NCT06916143 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06916143
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-08
- Primary completion
- 2026-08-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.